Ambu AS (CHIX:AMBUBC) Cyclically Adjusted Revenue per Share: kr17.26 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:AMBUBC Ambu AS CHIX:AMBUBC
80 GF Score
Price kr66.90
GF Value kr129.20
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Cyclically Adjusted Revenue per Share?

Ambu AS CHIX:AMBUBC 80 Cyclically Adjusted Revenue per Share is kr17.26 as of Mar. 2026. GuruFocus rates CHIX:AMBUBC with a GF Score™ of 80/100 and a GF Value™ of kr129.20 (Significantly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ambu AS's adjusted revenue per share for the three months ended in Mar. 2026 was kr5.980. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr17.26 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ambu AS's average Cyclically Adjusted Revenue Growth Rate was 9.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ambu AS was 17.60% per year. The lowest was 10.80% per year. And the median was 14.20% per year.

As of today (2026-07-14), Ambu AS's current stock price is kr66.90. Ambu AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr17.26. Ambu AS's Cyclically Adjusted PS Ratio of today is 3.88.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ambu AS was 41.52. The lowest was 3.53. And the median was 12.93.


Ambu AS  (CHIX:AMBUBc) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ambu AS's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=66.90/17.26
=3.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ambu AS was 41.52. The lowest was 3.53. And the median was 12.93.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ambu AS Cyclically Adjusted Revenue per Share Related Terms


Ambu AS Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ambu AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Cyclically Adjusted Revenue per Share Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.95 11.87 16.17 14.61 16.36

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.52 16.29 16.36 16.88 17.26

CHIX:AMBUBC vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Ambu AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambu AS Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ambu AS's Cyclically Adjusted PS Ratio falls into.


CHIX:AMBUBC
80GF Score
Ambu AS CHIX:AMBUBC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ambu AS's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.98/121.6800*121.6800
=5.980

Current CPI (Mar. 2026) = 121.6800.

Ambu AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2.109 100.600 2.551
201609 2.391 100.200 2.904
201612 2.178 100.300 2.642
201703 2.554 101.200 3.071
201706 2.492 101.200 2.996
201709 2.596 101.800 3.103
201712 2.173 101.300 2.610
201803 2.575 101.700 3.081
201806 2.704 102.300 3.216
201809 3.006 102.400 3.572
201812 2.603 102.100 3.102
201903 3.140 102.900 3.713
201906 3.113 102.900 3.681
201909 2.461 102.900 2.910
201912 3.076 102.900 3.637
202003 3.994 103.300 4.705
202006 3.809 103.200 4.491
202009 3.482 103.500 4.094
202012 4.007 103.400 4.715
202103 4.004 104.300 4.671
202106 3.766 105.000 4.364
202109 4.045 105.800 4.652
202112 4.124 106.600 4.707
202203 4.424 109.900 4.898
202206 4.431 113.600 4.746
202209 4.517 116.400 4.722
202212 4.631 115.900 4.862
202303 4.756 117.300 4.934
202306 4.452 116.400 4.654
202309 4.721 117.400 4.893
202312 4.771 116.700 4.975
202403 5.126 118.400 5.268
202406 5.160 118.500 5.298
202409 5.240 118.900 5.363
202412 5.611 118.900 5.742
202503 5.869 120.200 5.941
202506 5.636 120.700 5.682
202509 5.482 121.600 5.486
202512 5.809 121.200 5.832
202603 5.980 121.680 5.980

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr17.26 mean?
Ambu AS (CHIX:AMBUBC) has a Cyclically Adjusted Revenue per Share of kr17.26 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ambu AS and its competitors.
Is Ambu AS's Cyclically Adjusted Revenue per Share too high?
Ambu AS's current Cyclically Adjusted Revenue per Share is kr17.26. Overall, Ambu AS has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Ambu AS's Cyclically Adjusted Revenue per Share of kr17.26 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ambu AS and its competitors. Ambu AS's current Cyclically Adjusted Revenue per Share is kr17.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (CHIX:AMBUBC) is currently considered Significantly Undervalued. The stock's GF Value™ is kr129.20, compared to a current price of kr66.90 — trading 48.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr17.26. Ambu AS's overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ambu AS (CHIX:AMBUBC), the current Cyclically Adjusted Revenue per Share is kr17.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (CHIX:AMBUBC) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of kr66.90 is trading 48.2% below its estimated GF Value™ of kr129.20. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for CHIX:AMBUBC:

  • Cyclically Adjusted Revenue per Share: kr17.26
  • GF Value™: kr129.20 vs. price of kr66.90 (48.2% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the CHIX:AMBUBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
80GF Score

Get the complete analysis for CHIX:AMBUBC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr66.90
Price
kr129.20
GF Value